Forecasting individual pharmacokinetics

@article{Sheiner1979ForecastingIP,
  title={Forecasting individual pharmacokinetics},
  author={Lewis B. Sheiner and Stuart L. Beal and B Rosenberg and Vinay V. Marathe},
  journal={Clinical Pharmacology \& Therapeutics},
  year={1979},
  volume={26}
}
Often drug dosage may be chosen rationally by use of plasma concentration (CP) as the “therapeutic” end point. The ability to accurately forecast the CP resulting from a dosage regimen is central to choosing that regimen. Traditionally forecasting has been attempted only by accounting for known influences on pharmacokinetics, such as sex, age, and renal disease. One must also adjust for previously observed CPs. Herein, we discuss and explain an approach to both of these tasks, mainly focusing… 
Antimicrobial breakpoint estimation accounting for variability in pharmacokinetics
TLDR
Compared to traditional methods, the weighted AUC approach gives a more powerful PK/PD link and reveals, through examples, interesting issues about the uniqueness of therapeutic outcome indices and antibiotic resistance problems.
Therapeutic Drug Monitoring of Imatinib
TLDR
Clinical interpretation of randomly measured imatinib plasma concentrations can be assisted by Bayesian TDM, and classical Bayesian MAP estimation can be applied even without consideration of the correlation between pharmacokinetic parameters.
Pharmacokinetic modelling--a prelude to therapeutic drug monitoring for all cancer patients?
  • I. Judson
  • Medicine
    European journal of cancer
  • 1995
TLDR
Two examples are given in this issue, illustrating how different methods can be used to develop limited sampling strategies, which allow an accurate prediction of drug exposure to be made on the basis of only one or two blood samples.
Population Pharmacokinetics Theory and Clinical Application
TLDR
A move towards the adoption of population pharmacokinetics as a routine procedure during drug development and, where appropriate, proceed to the establishment of control systems based on Bayesian feedback is encouraged.
Predicting individual phenytoin dosage
TLDR
This paper compares the Bayesian method as applied to phenytoin to two other prediction methods (and a baseline, nonfeedback one) and concludes that the superiority of the latter may be a general phenomenon.
The population approach to pharmacokinetic data analysis: rationale and standard data analysis methods.
TLDR
The standard approaches are discussed and illustrated (using nondeficient data) in order to introduce subsequent papers in which alternative data analysis methods for population parameter estimation are defined, discussed, and compared.
Evaluation of single-point phenytoin dosage prediction methods in pediatric patients.
TLDR
The use of method B is recommended to make routine PHT dosage adjustments in pediatric patients when only one dose and one concentration are available, and mean prediction error, mean absolute error (MAE), and root mean squared error (RMSE) were separately calculated for each method.
Application of Population Pharmacokinetic Modeling for Individualized Infliximab Dosing Strategies in Crohn Disease
TLDR
Individualized IFX dosing strategies in children with CD will be critical to consistently achieve trough concentrations associated with optimal outcomes, and a one-size-fits-all approach to dosing is inadequate.
Population Pharmacokinetic Models
TLDR
Using a new nonparametric expectation maximisation (NPEM) population modelling program and retrospective data from 129 preterm infants who received gentamicin in their own clinical setting, 2 population models were developed and the median proved a better measure of central tendency.
One‐point Feedback Control Method for Phenytoin Dosage Adjustment
TLDR
Routine clinical pharmacokinetic data collected from patients receiving phenytoin have been analysed to propose a new and simple equation that allowed the prediction of a dose needed to produce a desired steady‐state concentration with errors comparable with the Bayesian feedback method for therapeutic drug monitoring.
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 14 REFERENCES
Modelling of individual pharmacokinetics for computer-aided drug dosage.
Abstract A conceptual scheme and associated statistical methodology is presented which is designed to provide the basis for a clinically useful computer program to suggest optimal dosage regimens for
Individualization of phenytoin dosage regimens
TLDR
It was concluded that the use of individual pharmacokinetic parameters is practical and is also superior to the nomogram.
The serum level approach to individualization of drug dosage
  • J. Koch-weser
  • Medicine
    European Journal of Clinical Pharmacology
  • 2004
TLDR
The relationship between the serum concentration of a drug and the intensity of its pharmacodynamic action is influenced by many other factors, which must always be considered in interpretation of serum levels.
Determination of therapeutic and toxic serum digoxin concentrations by radioimmunoassay.
TLDR
A sensitive (0.2 ng per milliliter), precise, and specific radioimmunoassay for serum digoxin concentration has been developed, and may provide useful information to the clinician faced with the difficult problem of evaluating his patient's state of digitalization.
Optimal control analysis in the chemotherapy of IgG multiple myeloma.
TLDR
The Gompertzian model for the growth of a cancer cell population subject to losses due to the action of cycle nonspecific therapy is used for the determination of a chemotherapy program obtained from optimal control theory for bone cancer IgG multiple myeloma.
Reducation of digitalis toxicity by computer-assisted glycoside dosage regimens.
TLDR
Computer-assisted dosage regimens of digitalis leaf, digitoxin, digoxin, and deslanoside (Cedilanid-D®) have reduced the frequency of adverse reactions to such glycosides from 35% to 12% in mice treated with these drugs.
Kuritzky P: Theophylline therapy: nomogram guidelines
  • Ann Intern Med
  • 1977
Theophylline therapy: nomogram guidelines
  • Ann Intern Med
  • 1977
dividualization of phenytoin dosage regimens
  • CUN PHARMACOL THER
  • 1977
Digitalis assay and its clinical application.
  • S. Oparil
  • Medicine
    The Medical clinics of North America
  • 1976
...
1
2
...